- Home
- Publications
- Publication Search
- Publication Details
Title
Endoglin for tumor imaging and targeted cancer therapy
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 4, Pages 421-435
Publisher
Informa Healthcare
Online
2013-01-17
DOI
10.1517/14728222.2013.758716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene
- (2012) Hao Hong et al. BIOMATERIALS
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- Reduced Endoglin Activity Limits Cardiac Fibrosis and Improves Survival in Heart Failure
- (2012) Navin K. Kapur et al. CIRCULATION
- A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
- (2012) L. S. Rosen et al. CLINICAL CANCER RESEARCH
- Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells
- (2012) Hongyu Tian et al. EMBO JOURNAL
- Bevacizumab: overview of the literature
- (2012) Maria Ignez Braghiroli et al. Expert Review of Anticancer Therapy
- High Immunohistochemical Expression of TGF-β1 Predicts a Poor Prognosis in Cervical Cancer Patients who Harbor Enriched Endoglin Microvessel Density
- (2012) Hao Lin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Current Limitations of Molecular Magnetic Resonance Imaging for Tumors as Evaluated With High-Relaxivity CD105-Specific Iron Oxide Nanoparticles
- (2012) Katrin Dassler et al. INVESTIGATIVE RADIOLOGY
- Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue
- (2012) G. S. Karagiannis et al. MOLECULAR CANCER RESEARCH
- Positron Emission Tomography and Optical Imaging of Tumor CD105 Expression with a Dual-Labeled Monoclonal Antibody
- (2012) Yin Zhang et al. MOLECULAR PHARMACEUTICS
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- In vitro epithelial-to-mesenchymal transformation in human adult epicardial cells is regulated by TGFβ-signaling and WT1
- (2011) Noortje A. M. Bax et al. BASIC RESEARCH IN CARDIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
- (2011) Laurence M. Wood et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors
- (2011) D. Romero et al. CANCER RESEARCH
- Exploring anti-TGF-β therapies in cancer and fibrosis
- (2011) Lukas J. A. C. Hawinkels et al. GROWTH FACTORS
- CD105 Protein Depletion Enhances Human Adipose-derived Stromal Cell Osteogenesis through Reduction of Transforming Growth Factor β1 (TGF-β1) Signaling
- (2011) Benjamin Levi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
- (2011) Roselyne Castonguay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Prognostic Significance of Carbonic Anhydrase IX (CA-IX), Endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in Breast Cancer Patients
- (2011) Lidija Beketic-Oreskovic et al. PATHOLOGY & ONCOLOGY RESEARCH
- The Role of the TGF-β Coreceptor Endoglin in Cancer
- (2011) Eduardo Pérez-Gómez et al. TheScientificWorldJOURNAL
- Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
- (2010) L. J. A. C. Hawinkels et al. CANCER RESEARCH
- Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival
- (2010) Gino Marioni et al. HISTOPATHOLOGY
- Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
- (2010) Franck Lebrin et al. NATURE MEDICINE
- Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma
- (2010) E Pardali et al. ONCOGENE
- Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells
- (2010) Virginia Albiñana et al. THROMBOSIS AND HAEMOSTASIS
- Endoglin-Targeted Cancer Therapy
- (2010) Ben K. Seon et al. Current Drug Delivery
- The emerging role of TGF-β superfamily coreceptors in cancer
- (2009) Carmelo Bernabeu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Expression of endoglin (CD105) in cervical cancer
- (2009) H J Zijlmans et al. BRITISH JOURNAL OF CANCER
- ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration
- (2009) Bridgette N. Ray et al. CARCINOGENESIS
- Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance
- (2009) Simone Post et al. CARDIOVASCULAR RESEARCH
- Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
- (2009) E. Fonsatti et al. CARDIOVASCULAR RESEARCH
- Emerging role of bone morphogenetic proteins in angiogenesis
- (2009) Laurent David et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature
- (2009) Shima Uneda et al. INTERNATIONAL JOURNAL OF CANCER
- Endoglin in angiogenesis and vascular diseases
- (2008) Peter ten Dijke et al. ANGIOGENESIS
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Non-Smad pathways in TGF-β signaling
- (2008) Ying E Zhang CELL RESEARCH
- Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-β in Vascular Morphogenesis
- (2008) Matthew T. Holderfield et al. CIRCULATION RESEARCH
- Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
- (2008) R. S. Svatek et al. CLINICAL CANCER RESEARCH
- Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer
- (2008) J. A. Karam et al. CLINICAL CANCER RESEARCH
- Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
- (2008) N. A. Dallas et al. CLINICAL CANCER RESEARCH
- Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice
- (2008) Masanori Tsujie et al. INTERNATIONAL JOURNAL OF CANCER
- Endoglin (CD105) as a urinary and serum marker of prostate cancer
- (2008) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Expression of the Transforming Growth Factor-β Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques
- (2008) Pieter T.G. Bot et al. STROKE
- Endoglin-Mediated Vascular Remodeling: Mechanisms Underlying Hereditary Hemorrhagic Telangiectasia
- (2008) Franck Lebrin et al. TRENDS IN CARDIOVASCULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search